Stockysis — AI-Powered Stock News & Sentiment Analysis

OptimizeRx Authorizes $10M Buyback

Benzinga Newsdesk www.benzinga.com Neutral 78.2%

Neg 0% Neu 78.2% Pos 0%

Comments

No comments yet. Be the first!